Stocks
Zynerba Pharmaceuticals (ZYNE) P/E US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -1.14 | -4.23 | -1.77 | -3.01 | -0.65 | -1.64 | ||
| Changes by years, y/y, % | -77% | +271% | -58% | +70% | -78% | -33.7% | |||
Zynerba Pharmaceuticals. P/E
Zynerba Pharmaceuticals. P/E, changes, %
Zynerba Pharmaceuticals (ZYNE) P/E US GAAP (quarter values) |
||||||||
| 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | LTM ? | |||
| P/E | ? | -1.24 | -0.88 | -0.68 | -0.57 | -0.44 | -1.64 | |
| Changes by years, y/y, % | -79% | -80% | -78% | -74% | -64% | |||
| Changes by quarters, q/q, % | -44% | -29% | -23% | -17% | -22% | |||
